Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06876311 · ClinicalTrials.gov registry record

Observational Study to Evaluate the STALIF® C FLX, STALIF® M FLX, STALIF® L FLX Cages and FORTOS-C®

A clinical trial of Degenerative Cervical Disc Disease and Degenerative Lumbar Diseases, sponsored by Silony Medical.

Active
Registry status
100
Enrollment target
1
Study location

NCT06876311: Active study of Degenerative Cervical Disc Disease and Degenerative Lumbar Diseases, sponsored by Silony Medical.

NCT06876311 is a study of Degenerative Cervical Disc Disease and Degenerative Lumbar Diseases that is active but no longer recruiting, run by Silony Medical. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06876311, a study of Degenerative Cervical Disc Disease and Degenerative Lumbar Diseases, is active but no longer recruiting, sponsored by Silony Medical.

ACTIVE NOT RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Post-operative clinical outcome data on the devices used to treat spinal diseases are collected and evaluated in order to analyze the safety and performance of the implants used.

Primary Outcome

The Neck Disability Index (NDI) has 10 items that cover various aspects of daily functioning, such as pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation. Scoring: Each question contains six answer choices, scored from 0 (no disability) to 5 (complete disability). All section scores are then totaled. Scoring is reported on a 0-50 scale, 0 being the best possible score and 50 being the worst. Alternately, the score can be reported from 0-100. T

Interventions

  • DEVICE Anterior Cervical Interbody Fusion
  • DEVICE Anterior lumbar Interbody Fusion
  • DEVICE Lateral Lumbar Interbody Fusion

Study Locations (1)

California

  • Golden State Orthopedics and Spine - San Ramon

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-03-04
Est. Completion 2025-05-30
Silony Medical

2 total trials

What the registry record for NCT06876311 still lists

NCT06876311 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 2 conditions, with Degenerative Cervical Disc Disease appearing as the primary indexed condition, and to 3 interventions - of which Anterior Cervical Interbody Fusion is the first listed.

NCT06876311 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06876311 about?

NCT06876311 is a clinical study titled "Observational Study to Evaluate the STALIF® C FLX, STALIF® M FLX, STALIF® L FLX Cages and FORTOS-C®". Post-operative clinical outcome data on the devices used to treat spinal diseases are collected and evaluated in order to analyze the safety and performance of the implants used.

What is the current status of trial NCT06876311?

This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2025-03-04. Estimated completion is 2025-05-30.

What conditions does trial NCT06876311 study?

This clinical trial studies the following conditions: Degenerative Cervical Disc Disease, Degenerative Lumbar Diseases.

What interventions are being tested in trial NCT06876311?

The interventions under investigation include: Anterior Cervical Interbody Fusion (DEVICE), Anterior lumbar Interbody Fusion (DEVICE), Lateral Lumbar Interbody Fusion (DEVICE).

Who is sponsoring clinical trial NCT06876311?

This trial is sponsored by Silony Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06876311 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06876311, the US trial registry maintained by the National Library of Medicine. NCT06876311 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.